» Articles » PMID: 21229618

Mechanisms of M-cresol-induced Protein Aggregation Studied Using a Model Protein Cytochrome C

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 2011 Jan 14
PMID 21229618
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Multidose protein formulations require an effective antimicrobial preservative (AP) to inhibit microbial growth during long-term storage of unused formulations. m-cresol (CR) is one such AP, but it has been shown to cause protein aggregation. However, the fundamental physical mechanisms underlying such AP-induced protein aggregation are not understood. In this study, we used a model protein cytochrome c to identify the protein unfolding that triggers protein aggregation. CR induced cytochrome c aggregation at preservative concentrations that are commonly used to inhibit microbial growth. Addition of CR decreased the temperature at which the protein aggregated and increased the aggregation rate. However, CR did not perturb the tertiary or secondary structure of cytochrome c. Instead, it populated an "invisible" partially unfolded intermediate where a local protein region around the methionine residue at position 80 was unfolded. Stabilizing the Met80 region drastically decreased the protein aggregation, which conclusively shows that this local protein region acts as an aggregation "hotspot." On the basis of these results, we propose that APs induce protein aggregation by partial rather than global unfolding. Because of the availability of site-specific probes to monitor different levels of protein unfolding, cytochrome c provided a unique advantage in characterizing the partial protein unfolding that triggers protein aggregation.

Citing Articles

Chlorogenic Acid Enhances the Chaperone Potential of BSA at Physiological Concentrations on Model Protein Cytochrome c.

Khan S, Ansari N, Naeem A Cell Biochem Biophys. 2024; 83(1):845-856.

PMID: 39306822 DOI: 10.1007/s12013-024-01516-1.


A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant.

Caringal R, Hickey J, Sharma N, Jerajani K, Bewaji O, Brendle S Vaccines (Basel). 2024; 12(6).

PMID: 38932309 PMC: 11209183. DOI: 10.3390/vaccines12060580.


Development of the Extended Infusion Set and Its Mechanism of Action.

Zhang G, Cohen O, Chattaraj S J Diabetes Sci Technol. 2022; 18(2):454-459.

PMID: 35876264 PMC: 10973872. DOI: 10.1177/19322968221112120.


Antimicrobial adhesive films by plasma-enabled polymerisation of m-cresol.

Hartl H, Li W, Michl T, Anangi R, Speight R, Vasilev K Sci Rep. 2022; 12(1):7560.

PMID: 35534598 PMC: 9085887. DOI: 10.1038/s41598-022-11400-8.


Methylparaben as a preservative in the development of a multi-dose HPV-2 vaccine.

Miao C, Ma X, Fan J, Shi L, Wei J Hum Vaccin Immunother. 2022; 18(5):2067421.

PMID: 35471842 PMC: 9302532. DOI: 10.1080/21645515.2022.2067421.


References
1.
Chi E, Krishnan S, Randolph T, Carpenter J . Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res. 2003; 20(9):1325-36. DOI: 10.1023/a:1025771421906. View

2.
Dong A, Huang P, Caughey W . Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry. 1990; 29(13):3303-8. DOI: 10.1021/bi00465a022. View

3.
Gupta S, Kaisheva E . Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. AAPS PharmSci. 2003; 5(2):E8. PMC: 2751516. DOI: 10.1208/ps050208. View

4.
Akers M . Excipient-drug interactions in parenteral formulations. J Pharm Sci. 2002; 91(11):2283-300. DOI: 10.1002/jps.10154. View

5.
Barth A . The infrared absorption of amino acid side chains. Prog Biophys Mol Biol. 2001; 74(3-5):141-73. DOI: 10.1016/s0079-6107(00)00021-3. View